|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Brucella IgM ELISA | Anti-Ustekinumab (Stelara®) ELISA | CA 242 ELISA Assay | Glutamate ELISA Assay | Syndecan ELISA Assay |
| Citations | | | | | |
| Catalog Number | IB05019 | TM09036 | 101-85 | IB89151R | 27188 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme linked immunosorbent assay (ELISA) for the determination of human IgM antibodies directed against pathogenic Brucella ssp. in serum and plasma (EDTA, citrate, heparin). For research use only, not for use in diagnostic procedures. | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | Solid phase sandwich ELISA for the determination of CA 242 cancer antigen in serum. For research use only, not for use in diagnostic procedures. Please note this assay has a 5 kit purchase minimum. | Enzyme Immunoassay (ELISA) for the determination of L-Glutamate in urine and various biological samples. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of Human Syndecan-4 in serum, EDTA plasma and cell culture supernatant. For research use only, not for use in diagnostic procedures. |
| Detection Target | Brucella IgM | sAPP Total | Complement Factor P (Properdin) | FSH | Angiotensinogen (Intact) |
| Sample Type | Serum and plasma (EDTA, citrate, heparin). | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Human serum or EDTA plasma. | Serum | Serum, EDTA plasma, and urine. |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | A calculated cut-off value is used to interpret results of unknowns. | Anti-Ustekinumab (Stelara®) | 15 to 150 U/mL | 0.6 to 60 µg/mL | 20 to 1280 pg/mL |
| Sensitivity | > 92% | 0.06 ng/mL | Inquire | Inquire | 0.093 ng/mL |
| Assay Time | 1 hour (37°C) + 30 min. (37°C) + 30 min. (37°C) = 2 hours total incubation time. | 2 hour, 30 min. total incubation time. | 3 hrs 30 mins (incubation) | 5 hrs 20 mins (incubation) | 2 hrs (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |